SCHEMBL17339764

SCHEMBL17339764

CC(C)(C)c1cccc(OCC23CCC(CC2)CC3)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOD1 P00441 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ GRM2 Q14416 1/20 0.40
▸ HTR1A P08908 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ FFAR1 O14842 3/20 0.39
▸ PPARG P37231 2/20 0.39
▸ PPARD Q03181 2/20 0.39
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CHRNB4 P30926 1/20 0.35
▸ CHRNA3 P32297 1/20 0.35
▸ TACR1 P25103 1/20 0.35
▸ TRPV1 Q8NER1 1/20 0.34
▸ DHFR P00374 1/20 0.34
▸ NR4A1 P22736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13165306 0.83 SOD1 (0.43) SOD1LMNAPOLBHTTL3MBTL1
SCHEMBL13165331 0.83 SOD1 (0.43) SOD1LMNAPOLBHTTL3MBTL1
SCHEMBL2742871 0.75 SOD1 (0.44) SOD1LMNAPOLBHTTL3MBTL1
SCHEMBL12062257 0.75 SOD1 (0.44) SOD1LMNAPOLBHTTL3MBTL1
SCHEMBL10064809 0.74 GRM2 (0.50) SOD1LMNAPOLBHTTL3MBTL1
SCHEMBL12062270 0.73 SOD1 (0.42) SOD1LMNAPOLBHTTL3MBTL1
SCHEMBL11937239 0.72 GRM2 (0.48) SOD1LMNAPOLBHTTL3MBTL1
SCHEMBL20347939 0.72 GRM2 (0.48) SOD1LMNAPOLBHTTL3MBTL1
SCHEMBL29979999 0.71 CYP3A4 (0.55) SOD1LMNAPOLBHTTL3MBTL1
SCHEMBL5619009 0.71 CYP3A4 (0.55) SOD1LMNAPOLBHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296737-B2 Substituted 2,4-diaminopyrimidines as kinase inhibitors CELGENE AVILOMICS RESEARCH, INC. (US) 2016-03-29 — — US disclosed
US-9212181-B2 Substituted 2,4-diaminopyrimidines as kinase inhibitors CELGENE AVILOMICS RESEARCH, INC. (US) 2015-12-15 — — US disclosed
Send feedback